CNMD

CNMD EBITDA

$185.52MTTM · USD

Period ending:

CNMD FY EBITDAUSD
CNMD FY EBITDA1986-12-31: $1.70M1987-12-31: $2.20M1988-12-31: $1.70M1989-12-31: $1.30M1990-12-31: $6.00M1991-12-31: $8.20M1992-12-31: $8.00M1993-12-31: $1.40M1994-12-31: $12.80M1995-12-31: $23.80M1996-12-31: $32.00M1997-12-31: $32.80M1998-12-31: $84.80M1999-12-31: $100.50M2000-12-31: $93.95M2001-12-31: $99.11M2002-12-31: $101.72M2003-12-31: $112.71M2004-12-31: $89.20M2005-12-31: $94.53M2006-12-31: $25.25M2007-12-31: $112.53M2008-12-31: $111.97M2009-12-31: $66.52M2010-12-31: $94.58M2011-12-31: $47.06M2012-12-31: $111.83M2013-12-31: $104.11M2014-12-31: $98.52M2015-12-31: $95.05M2016-12-31: $90.04M2017-12-31: $105.48M2018-12-31: $133.11M2019-12-31: $146.25M2020-12-31: $118.28M2021-12-31: $179.33M2022-12-31: $27.56M2023-12-31: $172.00M2024-12-31: $251.63M2025-12-31: $176.49M$251.63M$0.00
1986-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CNMD ebitda history

Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 40 observations from Dec 31, 1986 to Dec 31, 2025.

Conmed Corp EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
176,485,000
251,631,000
172,003,000
27,562,000
179,333,000
118,280,000
146,249,000
133,108,000
105,483,000
90,043,000
95,054,000
98,520,000
104,112,000
111,826,000
47,058,000
94,577,000
66,524,000
111,971,000
112,525,000
25,248,000
94,534,000
89,204,000
112,709,000
101,719,000
99,106,000
93,951,000
100,500,000
84,800,000
32,800,000
32,000,000
23,800,000
12,800,000
1,400,000
8,000,000
8,200,000
6,000,000
1,300,000
1,700,000
2,200,000
1,700,000

Compare ebitda

Other companies in Health Care. Each page shows its own reporting periods and currency.

All CNMD financial metrics · CNMD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.